ConductScience.org, home

Paper11700577

A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.

Shanks GD and 7 others. Clin Infect Dis, 2001. Cited by 130 papers, by iCite.

Cite this record

ConductScience Library. A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Papers, record 11700577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11700577

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2001
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
130
iCite
Relative citation ratio, by iCite
3.92
iCite
Revised in PubMed
2012-11-15
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shanks GDG D
2Oloo AJA J
3Aleman GMG M
4Ohrt CC
5Klotz FWF W
6Braitman DD
7Horton JJ
8Brueckner RR

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoquinolinesMajor topic
AntimalarialsMajor topic
Malaria, FalciparumMajor topic
Adolescent
Adult
Animals
Chemoprevention
Double-Blind Method
Female
Humans
Male
Middle Aged
Plasmodium falciparum
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05203744Escalating Monthly Doses of Tafenoquine in Healthy VolunteersBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.

PMIDTitleJournalYearIn PapersSource
42188870Tafenoquine: A Breakthrough Option for Babesiosis Treatment.Trop Med Infect Dis2026https://conductscience.org/library/papers/42188870PubMed
40305823The discovery of chloramphenicol treatment for both scrub typhus and typhoid fever.MSMR2025https://conductscience.org/library/papers/40305823PubMed
40132008Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/40132008PubMed
38837364The human malaria-Aotus monkey model: a historical perspective in antimalarial chemotherapy research at the Gorgas Memorial Laboratory-Panama.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38837364PubMed
38728310The PreQuine Platform: A novel diagnostic tool for measuring glucose-6-phosphate dehydrogenase (G6PD) activity and hemoglobin concentration.PLoS One2024https://conductscience.org/library/papers/38728310PubMed
38687748Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.PLoS One2024https://conductscience.org/library/papers/38687748PubMed
38259757Vivax malaria: a possible stumbling block for malaria elimination in India.Front Public Health2023https://conductscience.org/library/papers/38259757PubMed
38241389Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing.PLoS One2024https://conductscience.org/library/papers/38241389PubMed
37242320A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria.Pathogens2023https://conductscience.org/library/papers/37242320PubMed
36472067The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis.Elife2022https://conductscience.org/library/papers/36472067PubMed
35544095Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.Lancet Microbe2022https://conductscience.org/library/papers/35544095PubMed
34526770Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives.Ther Clin Risk Manag2021https://conductscience.org/library/papers/34526770PubMed
34495956Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34495956PubMed
34270547Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34270547PubMed
34050367Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?J Travel Med2021https://conductscience.org/library/papers/34050367PubMed
33979164
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1H)-Quinolones with Single Dose Cures.
J Med Chem2021https://conductscience.org/library/papers/33979164PubMed
33306921Tafenoquine: a toxicity overview.Expert Opin Drug Saf2021https://conductscience.org/library/papers/33306921PubMed
32892362Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32892362PubMed
32169086Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.Malar J2020https://conductscience.org/library/papers/32169086PubMed
32036613Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.Med J Aust2020https://conductscience.org/library/papers/32036613PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11700577

GET https://conductscience.org/api/papers/v1/11700577/cited_by?page=2